282 related articles for article (PubMed ID: 12905099)
1. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship.
Ulrich S; Northoff G; Wurthmann C; Partscht G; Pester U; Herscu H; Meyer FP
Pharmacopsychiatry; 2001 Jan; 34(1):33-40. PubMed ID: 11229620
[TBL] [Abstract][Full Text] [Related]
3. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
[TBL] [Abstract][Full Text] [Related]
5. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
Jungkunz G; Kuss HJ
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
[TBL] [Abstract][Full Text] [Related]
6. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
[TBL] [Abstract][Full Text] [Related]
7. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
[TBL] [Abstract][Full Text] [Related]
8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
9. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
10. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of tricyclic antidepressants in clinical practice.
Hollister LE
J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
Perry PJ; Zeilmann C; Arndt S
J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
[TBL] [Abstract][Full Text] [Related]
14. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
Miljković B; Pokrajac M; Timotijević I; Varagić V
Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of antidepressant drugs: pharmacogenetics.
Sjöqvist F; Bertilsson L
Adv Biochem Psychopharmacol; 1984; 39():359-72. PubMed ID: 6380229
[TBL] [Abstract][Full Text] [Related]
16. Specific radioimmunoassay for amitriptyline and nortriptyline in plasma.
Lucek R; Dixon R
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):125-36. PubMed ID: 905625
[TBL] [Abstract][Full Text] [Related]
17. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
Rosenberg C; Lauritzen L; Brix J; Jørgensen JB; Kofod P; Bayer LB
Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097
[TBL] [Abstract][Full Text] [Related]
18. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
[TBL] [Abstract][Full Text] [Related]
19. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel S; Bertschy G; Jounet JM; Allers G
Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
[TBL] [Abstract][Full Text] [Related]
20. [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
Schnyder C; Baumann P; Jonzier-Perey M; Koeb L; Wertheimer J
Schweiz Med Wochenschr; 1985 Aug; 115(33):1128-34. PubMed ID: 4035330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
